Cell Signaling Technology

DCLK1/DCAMKL1 (D2U3L) Rabbit Monoclonal Antibody

#62257 · $178

7
Citing papers
227
Combined citations
Supplier page Find this product

Research areas

Cancer Cells and Metastasis1Cancer Mechanisms and Therapy1Cancer-related molecular mechanisms research1Circular RNAs in diseases1Cytokine Signaling Pathways and Interactions1Endoplasmic Reticulum Stress and Disease1Eosinophilic Esophagitis1Asthma and respiratory diseases1

Papers citing this product

1
Complement receptor C3aR1 controls neutrophil mobilization following spinal cord injury through physiological antagonism of CXCR2
JCI Insight·2019·101 cit.·DOI
2
Suppressing STAT5 signaling affects osteosarcoma growth and stemness
Cell Death and Disease·2020·95 cit.·DOI
3
Epithelial cell specific Raptor is required for initiation of type 2 mucosal immunity in small intestine
Scientific Reports·2017·20 cit.·DOI
4
Tuft cells are required for a rhinovirus-induced asthma phenotype in immature mice
JCI Insight·2023·10 cit.·DOI
5
MicroRNA‑223‑5p suppresses the progression of nasopharyngeal carcinoma by targeting DCLK1
Oncology Letters·2021·1 cit.·DOI
6
Управление качеством электронного обучения на основе европейских стандартов
Высшее образование в России·2010·DOI
7
ATXN2L primarily interacts with NUFIP2, the absence of ATXN2L results in NUFIP2 depletion, and the ATXN2-polyQ expansion triggers NUFIP2 accumulation
bioRxiv (Cold Spring Harbor Laboratory)·2025·DOI

Similar products

ProductVendorPricePapers
DCLK1/DCAMKL1 (D2U3L) Rabbit Monoclonal Antibody (BSA and Azide Free)RabbitCell Signaling Technology$865100
DCLK1/DCAMKL1 (D2U3L) Rabbit Monoclonal Antibody — Evidence — PubIndex